Results per Page:
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
Meshinchi’s research training the body to fight cancer is expanding from blood cancers to solid tumors
Giving CAR T a second life in osteosarcoma
From the Meshinchi Lab, Clinical Research Division and Translational Science and Therapeutics Division
Age-dependent genetic alterations in AML patients
From the Meshinchi Lab, Translational Science & Therapeutics Division
New initiative bolsters Washington state life sciences
Fred Hutch researchers awarded over $4M in grants from the Washington Research Foundation
Flipping out to develop an intracellular protein-targeting CAR T cell therapy to treat AML
From the Meshinchi Lab, Clinical Research and Translational Science and Therapeutics Divisions.
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies
From the Meshinchi Lab, Clinical Research Division
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome
Pediatric acute myeloid leukemia targeted therapies come of age
From Dr. Hamid Bolouri, Human Biology and Dr. Soheil Meshinchi, Clinical Research Divisions
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more